In a regulatory filing, Cingulate (CING) disclosed that on August 7, the employment of Laurie Myers, Executive Vice President and Chief Operating Officer, terminated.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CING:
- Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating
- Cingulate Inc Submits NDA for ADHD Treatment
- Cingulate submits CTx-1301 NDA to FDA
- Cingulate Inc. Receives Buy Rating: PDUFA Fee Waiver and Competitive Edge of CTx-1301 Boost Market Prospects
- Cingulate receives $4.3M waiver from FDA for NDA for CTx-1301